Electrochemotherapy and inducible T cell co-stimulator (iCOS) antibody therapy: a novel combinational therapy for the enhanced treatment in cancers of poor prognosis

Benzer Materyaller

• Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
  Yazar:: Bosch, Ernesto, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain
  Yazar:: O’Brien, Carleigh A., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
  Yazar:: Zamarin, Dmitriy, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Macrophages in Breast Cancer: Do Involution Macrophages Account for the Poor Prognosis of Pregnancy-Associated Breast Cancer?
  Yazar:: O’Brien, Jenean, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Plasmacytoid Dendritic Cells and ICOS(+) Regulatory T Cells Predict Poor Prognosis in Gastric Cancer: A Pilot Study
  Yazar:: Liu, Xiaosun, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)